US president signs executive order to regulate AI in healthcare

A presidential executive order aimed at establishing a new set of guidelines and intended regulations for Artificial Intelligence (AI) has been issued by the United States government.

The Joe Biden administration on 30 October released what it describes as a new standard for AI safety and security, including calling for the responsible use of the technology in the healthcare sector in hopes of driving new drug discovery.

The executive order will require AI developers to share their safety test results and other critical information with the U.S. government, as well as calling for the development of methods to protect against the risks of using AI to engineer dangerous biological materials.

The Joe Biden administration on 30 October released what it describes as a new standard for AI safety and security, including calling for the responsible use of the technology in the healthcare sector in hopes of driving new drug discovery.

The executive order will require AI developers to share their safety test results and other critical information with the U.S. government, as well as calling for the development of methods to protect against the risks of using AI to engineer dangerous biological materials.

The new directive is also calling for voluntary commitments from companies working in the field of AI to develop methods intended to better ensure that, as the field of research continues to grow, the safety and personal security of US citizens is preserved.

The executive order reads: “By developing strong new standards for biological synthesis screening. Agencies that fund life-science projects will establish these standards as a condition of federal funding, creating powerful incentives to ensure appropriate screening and manage risks potentially made worse by AI.”

The US directive comes after the UK Prime Minister, Rishi Sunak, vowed to tackle fears surrounding AI ahead of the world’s first AI safety summit. Medical Device Network